Surgical Specialty Leads for clinical trials

The BOA is, for the first time, sponsoring ‘Surgical Specialty Leads’ for trauma and orthopaedics and three excellent candidates have been appointed to these roles and take up these positions as 1st November 2019. These positions will cost £62,500 over three years and have been funded as a result of our research fundraising. We are really grateful to all those members, donors, fundraisers and supporters, who have so generously donated and supported this work.

The Surgical Specialty Leads are positions coordinated through the RCSEngland and the aim is for them to act as a conduit for clinicians interested in developing trials and to provide a forum for discussion of proposals that can be processed through appropriate funding bodies. They will each chair a clinical research group to help develop new trials in their field. The three appointees will work collaborative with the BOA, with our funded clinical trials unit and with other stakeholder individuals to make progress in supporting development of research and trial.

Mr Peter Hutchinson, Director of Clinical Research at the Royal College of Surgeons of England, commented:

“The appointment of three new surgical speciality leads in Orthopaedics and Trauma is a fantastic development. It provides a major opportunity to broaden the spectrum of clinical research and the surgical trial portfolio. Their research will enable  important questions to answered  and improve the treatment for patients with disorders of and injury to the musculo-skeletal system.”

Biographies for the three appointees are provided below. We will be supporting them over the next three years and will provide members and donors updates on their progress and ways to get involved.

Surgical Specialty Leads

Daniel Perry image

Daniel Perry

Daniel Perry is Associate Professor of Children’s Trauma and Orthopaedic Surgery at the University of Oxford, an NIHR Clinician Scientist and a Consultant Children's Orthopaedic Surgeon Alder Hey Children’s Hospital in Liverpool. 

Dan has united surgeons throughout the UK, such that they are now working together to change the face of children’s research worth about £7m. Dan’s love is to make clinical trials accessible – both to children, parents and surgeons. He keenly integrates cartoons, animations, videos and text message communication to make trials easy for everyone! 

Dan is a member of the NIHR HTA Commissioning Board, is an Editor of the Bone and Joint Journal and is the clinical lead for hip screening within Public Health England.

Paul Baker image

Paul Baker

Paul Baker is a clinical academic at the South Tees Hospital NHS Foundation Trust and has undertaken a significant amount of research in to the outcomes of patients undergoing hip and knee replacement procedures. He was the NJR’s first research fellow, and founded the CORNET orthopaedic trainee research collaborative whilst a trainee in the Northern Deanery. Paul is the current director of research and innovation for the South Tees Hospitals and an executive director for the Durham Tees Valley Research Alliance with responsibility for a portfolio of over 200 clinical studies. He is a NIHR grant holder and chief investigator for the OPAL study that completed in early 2019. He is currently developing the next phase of the OPAL study which will involve a multicentre clinical trial.

Xavier Griffin image

Xavier Griffin

Xavier Griffin is an Associate Professor of Trauma Surgery at the University of Oxford and Honorary Consultant Trauma Surgeon at the John Radcliffe Hospital. His clinical interests are in the care of the multiply injured patient and those with pelvic and acetabulum fractures.

He is currently an NIHR Clinician Scientist, with research interests in clinical and cost effectiveness of treatments for patients sustaining injuries, and is the Chief Investigator for several NIHR randomised clinical trials. Current studies include those related to broken hips, broken ankles and pelvic fractures.

Xavier has several research committee appointments including, but not limited to; Cochrane Bone Joint and Muscle Trauma Group, Arthritis UK and British Orthopaedic Trauma Society.